Table 1.

Clinical characteristics for the patients enrolled in this study.

Information	Case group		Control group
	Total	P value	Total	P value
Number of patients	39		27
Age (years)∗	33.8 ± 14.7 (16–65)	P > 0.05	36.7 ± 15.1 (21–60)	P > 0.05
Gender (male/female)	9/30	P < 0.05	8/19	P < 0.05
Site
Kidney	26
Lung	9
Heart	12
Skin	15
Stage
Active stage (≥3)	27	P < 0.05
Remittent stage (<3)	12

^∗Stands for the mean ± SEM (range).